Quick Details

• ProName: Atosiban Acetate
• CasNo: 90779-69-4
• Molecular Formula: C43H67N11O12S2
• Appearance: white powder
• Application: peptide,custom peptides,cosmetic pepti...
• DeliveryTime: 7DAYS
• PackAge: 1G/BAG,10G/BAG
• Port: SHANGHAI
• ProductionCapacity: 20 Kilogram/Month
• Purity: 99%
• Storage: -20℃
• Transportation: 2-8degree
• LimitNum: 1 Gram
• Moisture Content: 1%
• Impurity: 0.2%
• Atosiban Acetate can postpone its imminent premature birth.
  
  Mechanism of action: Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. As a result, there is reduced release of intracellular, stored calcium from the sarcoplasmic reticulum of myometrial cells, and reduced influx of Ca2+ from the extracellular space through voltage gated channels. In addition, atosiban suppresses oxytocin-mediated release of PGE and PGF from the decidua.
  
  Originator Company: Ferring Pharmaceuticals
  
  Dosage for formulation: 7.5mg/ml
  
  Generic API process in our company: Atosiban Acetate is one of our main peptide projects, related documents will be submitted to the international FDA.